Man Group’s Starling Oncology Warrant STLNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75K Hold
88,824
– – ﹤0.01% 2316
2026
Q1
$4.94K Hold
88,824
– – ﹤0.01% 2367
2025
Q4
$14.2K Hold
88,824
– – ﹤0.01% 2223
2025
Q3
$11.9K Hold
88,824
– – ﹤0.01% 2179
2025
Q2
$4.56K Hold
88,824
– – ﹤0.01% 2145
2025
Q1
$2.13K Hold
88,824
– – ﹤0.01% 2150
2024
Q4
$622 Hold
88,824
– – ﹤0.01% 1963
2024
Q3
$1.78K Hold
88,824
– – ﹤0.01% 1942
2024
Q2
$1.8K Hold
88,824
– – ﹤0.01% 1998
2024
Q1
$20K Hold
88,824
– – ﹤0.01% 2094
2023
Q4
$11.5K Buy
+88,824
New +$14K ﹤0.01% 2023
2023
Q3
– Sell
-94,740
Closed -$7.71K – 1890
2023
Q2
$4.26K Buy
+94,740
New +$5.21K ﹤0.01% 1938
2023
Q1
– Sell
-94,740
Closed -$11.7K – 2048
2022
Q4
$10.4K Hold
94,740
– – ﹤0.01% 1981
2022
Q3
$48K Buy
+94,740
New +$66K ﹤0.01% 1898
2022
Q2
– Sell
-94,740
Closed -$87.2K – 2404
2022
Q1
$109K Hold
94,740
– – ﹤0.01% 2043
2021
Q4
$65K Hold
94,740
– – ﹤0.01% 1898
2021
Q3
$120K Hold
94,740
– – ﹤0.01% 1803
2021
Q2
$164K Hold
94,740
– – ﹤0.01% 1823
2021
Q1
$114K Hold
94,740
– – ﹤0.01% 1793
2020
Q4
$185K Hold
94,740
– – ﹤0.01% 1745
2020
Q3
$161K Buy
+94,740
New +$156K ﹤0.01% 1717

Other funds holding STLNW

Man Group's STLNW Position: Q2 2026 in Review

Man Group held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 88,824 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

Man Group first reported a position in STLNW in Q3 2020 and has held it in 21 quarters since. The position peaked at $185K in Q4 2020. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

  • Man Group held 88,824 shares of Starling Oncology Warrant worth $2.75K as of Q2 2026.
  • Man Group left its Starling Oncology Warrant share count unchanged in Q2 2026.
  • Starling Oncology Warrant made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2316 holding.
  • Man Group first reported a position in Starling Oncology Warrant in Q3 2020 and has held it in 21 quarters since.
  • Man Group's Starling Oncology Warrant position peaked at $185K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.